Bringing Hope to Life

Make an appointment
Call us: 206.515.0000

Success
At Pacific NW Fertility, we know that having a baby is the ultimate goal of your fertility journey. We have assembled the best team, state-of-the-art laboratory and best-practice technology to help you achieve a pregnancy. 
 
Below are clinical pregnancy rates as outlined by Society for Assisted Reproductive Technology (SART) and published by the Centers for Disease Control. (A clinical pregnancy rate at Pacific NW Fertility is defined as a positive fetal heart tone confirmed under ultrasound guidance at 7 weeks. These rates combine transfers performed on Day 3 and at the Blastocyst stage on Day 5.)
  
 
 
 

Understanding Success Rates

A programs success is attributed to a variety of factors including the experience and dedication of the physician and laboratory teams, individualized IVF protocols, as well as laboratory conditions and techniques. A comparison of clinic success rates may not be meaningful because patient medical characteristics and treatment approaches may vary from clinic to clinic.
 
Most U.S. fertility programs follow the guidelines of the Society for Assisted Reproductive Technology (SART) to report success rates. SART has developed a national database for reporting fertility treatment outcomes. The report is generated by SART and published by the Centers for Disease Control (CDC). This system assures consistency in reporting clinic outcomes around the country. For more information, see the CDC website.
 

Guidelines

Pacific NW Fertility follows guidelines on number of embryos transferred that are set forth by the American Society of Reproductive Medicine. Those guidelines are:

A) In patients under the age of 35 and for patients using donor oocytes, no more than 2 embryos should be transferred in the absence of extraordinary circumstances. For patients with the most favorable prognosis, consideration should be given to transferring only a single embryo.
 
B) For patients between 35 and 37 years of age having a more favorable prognosis, no more than 2 embryos should be transferred. All others in this age group should have no more than 3 embryos transferred.
 
C) For patients between 38 and 40 years of age, no more than 4 embryos should be transferred. For patients in this age group having a more favorable prognosis, consideration should be given to transfer of no more than 3 embryos.
 
D) For most patients greater than 40 years of age, no more than 5 embryos should be transferred.